Skip to main content
. 2025 Aug 22;17(3):242–255. doi: 10.4274/jcrpe.galenos.2024.2024-4-15

Table 1. Classification and etiology of congenital hypothyroidism .

Permanent congenital hypothyroidism

1.Primary hypothyroidism

a) Thyroid dysgenesis: ectopia, athyreosis, hypoplasia, hemiagenesis

i) Familial or genetic (2-5% of dygenesis cases): syndrome or associated features

(1) NKX2.1: Brain-lung-thyroid syndrome (respiratory distress, choreatetosis)

(2) FOXE1: Bamforth-Lazarus syndrome (cleft palate, chonal atresia, spiky hair)

(3) PAX8: Hypoplasia, genitourinary anomalies (rare)

(4) GLIS3: Athyreosis, neonatal diabetes, cystic kidneys, cholestasis

(5) NKX2.5: Athyreosis/ectopy, congenital heart malformations

(6) JAG1: Hypoplasia/ectopy, Alagille syndrome type 1

(7) CDC8 (BOREALIN): Ectopy, athyreosis, hemiagenesis

(8) NTN1 (Netrin1), TUBB1 (Tubulin1): Ectopy

ii) Sporadic (95-98% unknown etiology)

b) Dyshormonogenesis: impaired hormone production (±goiter) due to defects in

i) Iodide uptake by sodium-iodide symporter (NIS-SLC5A5)

ii) Iodide transport from follicular cell into colloid

(1) SLC26A4 (PDS): Pendred syndrome (deafness with goiter)

(2) SLC26A7: Normal hearing

iii) Iodide organification by TPO

iv) Hydrogen peroxide generation

(1) Dual oxidase 2 (DUOX2) or activator/maturation factor 2 (DUOXA2)

(2) Dual oxidase 1 (DUOX1) or activator/maturation factor 1 (DUOXA1)

v) Thyroglobulin synthesis (TG)

vi) Deiodination by iodotyrosine deiodinase/dehalogenase (IYD-DEHAL1)

c) TSH resistance

i) Defect in TSH receptor (TSHR): Normal-sized thyroid to severe hypoplasia

ii) Defect in G-protein signalling (GNAS): Pseudohypoparathyroidism type 1a

d) Syndromic primary hypothyroidism (usually with normal thyroid morphology)

i) TBX1: Di George syndorme

ii) ELN: Williams-Beuren syndrome

iii) DYRK1A: Down syndrome

iv) SALL1 (Townes-Brocks), URB1 (Johanson-Blizzard), KMT2D, KDM6A (Kabuki)

2. Central hypothyroidism

a) Secondary (pituitary) hypothyroidism

i) Isolated TSH deficiency (TSHβ): Low TSH, pitutary hyperplasia

ii) TRH receptor resistance (TRHR): Low TSH and prolactin

iii) Combined pituitary deficiencies (HESX1, LHX3, LHX4, PIT1, PROP1, SOX3, OTX2)

b) Tertiary (hypothalamic) hypothyroidism

i) IGSF1: X-linked, low TSH/prolactin, delayed puberty, postpubertal macroorchidism

ii) TBLX1, IRS4: X-linked, inappropriately normal TSH, sensorineural deafness

iii) Combined pituitary deficiencies (LEPR, PROK2, FGF8, FGFR1, SOX2, CHD7)

Transient congenital hypothyroidism

1) Primary hypothyroidism

a) Maternal iodine deficiency (endemic goiter)

b) Maternal and neonatal iodine exposure

c) Maternal antithyroid medications (methimazole, propylthiouracil)

d) Maternal TSH receptor-blocking antibodies

e) Genetic defects (DUOX2, DUOXA2, TPO)

2) Central hypothyroidism

a) Maternal hyperthyroidism

b) Prematurity (particularly <27 weeks of gestation)

c) Drugs: Dopamin, steroids

TPO: thyroid peroxidase, TSH: thyroid-stimulating hormone, FT4: free thyroxine, NHT: neonatal hyperthyrotropinemia